BU Professor Wins FASEB Women's Science Award

BU Professor Wins FASEB Women's Science Award Citing the 22 years it took for her to gain tenure as a university professor, neuroendocrinologist Susan Leeman notes that her professional life has not been free of frustration. And she attributes much of this frustration to the fact that she is a woman. Moreover, the 63-year-old Leeman, recent winner of the Women's Excellence in Science Award, presented by the Federation of American Societies for Experimental Biology (FASEB), says the career pat

Written byRon Kaufman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BU Professor Wins FASEB Women's Science Award
Citing the 22 years it took for her to gain tenure as a university professor, neuroendocrinologist Susan Leeman notes that her professional life has not been free of frustration. And she attributes much of this frustration to the fact that she is a woman. Moreover, the 63-year-old Leeman, recent winner of the Women's Excellence in Science Award, presented by the Federation of American Societies for Experimental Biology (FASEB), says the career path for women in science today is not much easier than when she was starting out.

Leeman, a professor of pharmacology and experimental therapeutics at Boston University who is credited with the discovery of two major peptides, sums it up succinctly: "Women do have a more difficult time than men."

The five-year-old Women's Excellence in Science Award was presented by FASEB on March 31 at the Experimental Biology '93 meeting in New ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies